12.16
Schlusskurs vom Vortag:
$11.33
Offen:
$11.77
24-Stunden-Volumen:
2.55M
Relative Volume:
0.99
Marktkapitalisierung:
$2.04B
Einnahmen:
$1.00B
Nettoeinkommen (Verlust:
$-12.99M
KGV:
138.54
EPS:
0.0878
Netto-Cashflow:
$194.46M
1W Leistung:
+13.34%
1M Leistung:
+29.46%
6M Leistung:
+1.88%
1J Leistung:
-13.02%
Douglas Emmett Inc Stock (DEI) Company Profile
Firmenname
Douglas Emmett Inc
Sektor
Branche
Telefon
310-255-7700
Adresse
1299 OCEAN AVENUE, SUITE 1000, SANTA MONICA, CA
Compare DEI vs BXP, ARE, VNO, CUZ, KRC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DEI
Douglas Emmett Inc
|
12.20 | 1.90B | 1.00B | -12.99M | 194.46M | 0.0878 |
|
BXP
Bxp Inc
|
60.38 | 9.29B | 3.48B | 384.00M | 686.12M | 1.7389 |
|
ARE
Alexandria Real Estate Equities Inc
|
46.69 | 7.63B | 2.94B | -865.55M | 1.40B | -6.2735 |
|
VNO
Vornado Realty Trust
|
31.38 | 5.69B | 1.81B | 815.35M | 1.01B | 3.6417 |
|
CUZ
Cousins Properties Inc
|
26.94 | 4.29B | 1.01B | -4.51M | 125.43M | -0.0334 |
|
KRC
Kilroy Realty Corp
|
34.64 | 3.90B | 1.11B | 243.55M | 580.09M | 1.8259 |
Douglas Emmett Inc Stock (DEI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-14 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-11-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-07-16 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2025-03-17 | Eingeleitet | Jefferies | Hold |
| 2025-01-15 | Herabstufung | Janney | Buy → Neutral |
| 2025-01-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-01-02 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-11-14 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2024-01-02 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-09-05 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-08-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-04-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-03-03 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2023-01-09 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2023-01-03 | Herabstufung | Jefferies | Hold → Underperform |
| 2022-10-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-27 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-01-10 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2021-12-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-06-03 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-01-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-01-07 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-11-25 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-08-12 | Herabstufung | Jefferies | Buy → Hold |
| 2020-04-16 | Eingeleitet | Jefferies | Buy |
| 2020-03-25 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-02-04 | Fortgesetzt | Mizuho | Neutral |
| 2020-01-15 | Herabstufung | Mizuho | Buy → Neutral |
| 2018-12-20 | Hochstufung | Janney | Neutral → Buy |
| 2018-11-15 | Hochstufung | Sandler O'Neill | Hold → Buy |
| 2018-11-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-02-15 | Bestätigt | Stifel | Buy |
| 2017-11-09 | Bestätigt | Stifel | Buy |
| 2017-09-08 | Eingeleitet | Janney | Neutral |
| 2017-08-03 | Hochstufung | Stifel | Hold → Buy |
| 2017-02-10 | Bestätigt | Mizuho | Neutral |
| 2017-02-09 | Hochstufung | Stifel | Sell → Hold |
| 2016-12-13 | Herabstufung | UBS | Neutral → Sell |
| 2016-12-13 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-08-04 | Bestätigt | DA Davidson | Buy |
| 2016-08-04 | Herabstufung | Mizuho | Buy → Neutral |
| 2016-06-30 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Douglas Emmett Inc Aktie (DEI) Neueste Nachrichten
Douglas Emmett (NYSE:DEI) Issues Quarterly Earnings Results - MarketBeat
Douglas Emmett (DEI) Tops Q1 FFO Estimates - Yahoo! Finance Canada
Douglas Emmett Inc (NYSE:DEI) Q1 2026: EPS Beat Offsets Revenue Miss, Stock Flat - ChartMill
Douglas Emmett (NYSE:DEI) Updates FY 2026 Earnings Guidance - MarketBeat
DOUGLAS EMMETT ($DEI) Releases Q1 2026 Earnings - Quiver Quantitative
Douglas Emmett: Q1 Earnings Snapshot - kens5.com
Douglas Emmett, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
AFFO drops as Douglas Emmett (NYSE: DEI) issues 2026 loss outlook - Stock Titan
Douglas Emmett earnings ahead: Can the office REIT stem losses? - Investing.com
MSN Money - MSN
Douglas Emmett Q1 2026 earnings preview - MSN
Douglas Emmett (DEI) Q1 2026 Preview: Reports on May 6 - AlphaStreet
Douglas Emmett Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
2800 Neilson Way Unit 1521, Santa Monica, CA 90405 - Realtor.com
Vanguard reports 5.19% stake in Douglas Emmett Inc (DEI) - Stock Titan
How Douglas Emmett (DEI) Narrative Is Shifting As Analysts Reassess Growth And Valuation - Yahoo Finance
Vanguard Portfolio Management (DEI) holds 9.89% — 16.57M shares reported - Stock Titan
Douglas Emmett, Inc. (DEI) Stock Price Today - MEXC Exchange
Douglas Emmett (DEI) to Release Earnings on Tuesday - MarketBeat
Is Douglas Emmett (DEI) a great value stock right now? - MSN
Piper Sandler Downgrades Douglas Emmett (DEI) - MSN
Scotiabank Maintains Douglas Emmett (DEI) Sector Outperform Recommendation - MSN
Is Douglas Emmett (DEI) a Great Value Stock Right Now? - Yahoo Finance
Douglas Emmett declares $0.19 dividend - MSN
(DEI) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
A Look At Douglas Emmett (DEI) Valuation After The Bedford Collection Acquisition - Sahm
DEI (Douglas Emmett Inc.) posts narrower Q4 2025 loss than estimates, shares climb 2.45 percent. - Cổng thông tin điện tử Tỉnh Sơn La
Evercore ISI Group Updates Analyst Rating for Douglas Emmett (DE - GuruFocus
Is Douglas Emmett (DEI) Quietly Redefining Its Earnings Mix With Beverly Hills Medical Offices? - simplywall.st
Douglas Emmett (DEI) Price Target Decreased by 10.75% to 15.25 - MSN
Douglas Emmett, Inc. (NYSE:DEI) Given Average Rating of "Hold" by Analysts - MarketBeat
Douglas Emmett Inc stock (US25958P1066): Why Google Discover changes matter more now - AD HOC NEWS
A Look at Douglas Emmett Inc (DEI) After 3.6% Gain -- GF Value $14.26 vs Price $10.83 - GuruFocus
Douglas Emmett Lands HQ Lease at LA Office Tower - CommercialSearch
Douglas Emmett consolidates holdings in the Beverly Hills medical market with $260M acquisition - Santa Monica Mirror
Caruso blows past 7-figure mark in gubernatorial race - The Real Deal
Piper Sandler Maintains Douglas Emmett Inc(DEI.US) With Hold Rating, Maintains Target Price $11 - 富途牛牛
Douglas Emmett Pays $260M For Beverly Hills Med. Portfolio - Law360
Douglas Emmett Inc ($DEI) Chairman and CEO 2025 Pay Revealed - Quiver Quantitative
15M-share incentive plan, pay package face DEI (NYSE: DEI) vote - Stock Titan
[ARS] Douglas Emmett Inc SEC Filing - Stock Titan
Douglas Emmett pays $260M for Beverly Hills medical complex - The Real Deal
News | Douglas Emmett deal shows healthcare's rising clout in Beverly Hills real estate - CoStar
Wells Fargo Maintains Douglas Emmett Inc(DEI.US) With Buy Rating, Raises Target Price to $20 - 富途牛牛
A Look At Douglas Emmett (DEI) Valuation After Its Beverly Hills Medical Portfolio Acquisition - Sahm
Douglas Emmett acquires premier Beverly Hills medical office portfolio in JV - Institutional Real Estate, Inc.
Douglas Emmett Inc stock (US25958P1066): Why office demand in premium LA markets matters more now - AD HOC NEWS
Douglas Emmett Adds MOB Portfolio to Beverly Hills Holdings - Connect CRE
Douglas Emmett, Welltower Shake on $260M MOB Deal in LA - CommercialSearch
Massachusetts Financial Services Co. MA Sells 1,273,013 Shares of Douglas Emmett, Inc. $DEI - MarketBeat
Douglas Emmett Buys California Medical Portfolio in $260 Million JV Deal - marketscreener.com
Finanzdaten der Douglas Emmett Inc-Aktie (DEI)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):